Clinical trial

Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer

NCT01993810 · Radiation Therapy Oncology Group, Other · Active, not recruiting

Key facts

NCT number NCT01993810
Title Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
Official title Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB NSCLC
Lead sponsor Radiation Therapy Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH NRG Oncology
Status Active, not recruiting
Phase Phase 3
Study type Interventional
Conditions Stage II Non-Small Cell Lung Cancer AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7, Stage III Non-Small Cell Lung Cancer AJCC v7, Stage IIIA Non-Small Cell Lung Cancer AJCC v7, Stage IIIB Non-Small Cell Lung Cancer AJCC v7
Intervention type Biological, Drug, Other, Radiation
Interventions Carboplatin, Cisplatin, Durvalumab, Etoposide, Paclitaxel, Pemetrexed Disodium, Photon Beam Radiation Therapy, Proton Beam Radiation Therapy, Quality-of-Life Assessment, Questionnaire Administration
Enrollment 330
Start date Feb 3, 2014
Primary completion Dec 1, 2027
Completion Oct 1, 2028
First posted Nov 25, 2013
Last update posted Dec 18, 2024
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies